Search research articles
Contact Us
Filters
Showing results (841-850 of 905) with videos related to
Page
of 91
Sort By:
The European Respiratory Journal
|
August 25, 2018
Identifying obstructive sleep apnoea patients responsive to supplemental oxygen therapy
Scott A Sands, Bradley A Edwards, Philip I Terrill, et al.
Bone Marrow Transplantation
|
April 5, 2016
Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD
S-K Tey, S Vuckovic, A Varelias, et al.
Journal of Toxicology
|
June 14, 2013
Cumulative risk assessment toolbox: methods and approaches for the practitioner
Margaret M Macdonell, Lynne A Haroun, Linda K Teuschler, et al.
Iscience
|
November 10, 2021
A novel jamming phase diagram links tumor invasion to non-equilibrium phase separation
Wenying Kang, Jacopo Ferruzzi, Catalina-Paula Spatarelu, et al.
Laboratory Animals
|
April 8, 2006
Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals
P J O'Brien, D E C Smith, T J Knechtel, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
May 9, 2015
High-throughput screening for modulators of cellular contractile force
Chan Young Park, Enhua H Zhou, Dhananjay Tambe, et al.
Scientific Reports
|
October 28, 2020
Epithelial layer unjamming shifts energy metabolism toward glycolysis
Stephen J DeCamp, Victor M K Tsuda, Jacopo Ferruzzi, et al.
Database : the Journal of Biological Databases and Curation
|
May 26, 2011
Data mining using the Catalogue of Somatic Mutations in Cancer BioMart
Rebecca Shepherd, Simon A Forbes, David Beare, et al.
Nature Genetics
|
April 15, 2014
Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
Serena Nik-Zainal, David C Wedge, Ludmil B Alexandrov, et al.
Journal of Medicinal Chemistry
|
April 17, 1998
(3R,4S)-3-[4-(4-fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: a conformationally restricted analogue of the NR2B subtype-selective NMDA antagonist (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)- 1-propanol
T W Butler, J F Blake, J Bordner, et al.
Page
of 91
Search research articles
Search
Showing results (841-850 of 905) with videos related to
Sort By:
Page
of 91
The European Respiratory Journal
|
August 25, 2018
Identifying obstructive sleep apnoea patients responsive to supplemental oxygen therapy
Scott A Sands, Bradley A Edwards, Philip I Terrill, et al.
Bone Marrow Transplantation
|
April 5, 2016
Pharmacokinetics and immunological outcomes of alemtuzumab-based treatment for steroid-refractory acute GvHD
S-K Tey, S Vuckovic, A Varelias, et al.
Journal of Toxicology
|
June 14, 2013
Cumulative risk assessment toolbox: methods and approaches for the practitioner
Margaret M Macdonell, Lynne A Haroun, Linda K Teuschler, et al.
Iscience
|
November 10, 2021
A novel jamming phase diagram links tumor invasion to non-equilibrium phase separation
Wenying Kang, Jacopo Ferruzzi, Catalina-Paula Spatarelu, et al.
Laboratory Animals
|
April 8, 2006
Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals
P J O'Brien, D E C Smith, T J Knechtel, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro
|
May 9, 2015
High-throughput screening for modulators of cellular contractile force
Chan Young Park, Enhua H Zhou, Dhananjay Tambe, et al.
Scientific Reports
|
October 28, 2020
Epithelial layer unjamming shifts energy metabolism toward glycolysis
Stephen J DeCamp, Victor M K Tsuda, Jacopo Ferruzzi, et al.
Database : the Journal of Biological Databases and Curation
|
May 26, 2011
Data mining using the Catalogue of Somatic Mutations in Cancer BioMart
Rebecca Shepherd, Simon A Forbes, David Beare, et al.
Nature Genetics
|
April 15, 2014
Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
Serena Nik-Zainal, David C Wedge, Ludmil B Alexandrov, et al.
Journal of Medicinal Chemistry
|
April 17, 1998
(3R,4S)-3-[4-(4-fluorophenyl)-4-hydroxypiperidin-1-yl]chroman-4,7-diol: a conformationally restricted analogue of the NR2B subtype-selective NMDA antagonist (1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)- 1-propanol
T W Butler, J F Blake, J Bordner, et al.
Page
of 91